English | 简体中文 | 繁體中文 | 한국어 | 日本語
  Press Releases
Thursday, June 2, 2022
Boehringer Ingelheim Enters Global Licensing Agreement to Develop and Commercialize Innovative Antibodies from A*STAR for Targeted Cancer Therapies
Boehringer Ingelheim Enters Global Licensing Agreement to Develop and Commercialize Innovative Antibodies from A*STAR for Targeted Cancer Therapies
Thursday, September 30, 2021
A*STAR and Local SME Work with Vaccination Centres to Deploy AVID System for Filling Syringes
Friday, July 31, 2020
Singapore Cancer Drug ETC-159 Advances Further in Clinical Trials
Friday, July 24, 2020
MP Biomedicals and A*STAR Co-Develop Rapid Antibody Test Kit for SARS-CoV-2
Tuesday, October 22, 2019
Fujitsu, SMU and A*STAR Launch Digital Platform Experimentation Project using Quantum-Inspired Computing and Deep Learning Technology
Fujitsu, SMU and A*STAR Launch Digital Platform Experimentation Project using Quantum-Inspired Computing and Deep Learning Technology
Monday, October 21, 2019
富士通・シンガポール科学技術庁・Singapore Management University、「デジタルアニーラ」とディープラーニング技術を活用したプロジェクトを開始
Friday, June 28, 2019
Singapore's Drug Development Efforts Given Additional Momentum with National Platforms
Friday, April 5, 2019
Passing of Dr Sydney Brenner, Nobel Laureate, Renowned Pioneer in Molecular Biology, A*Star Senior Fellow

Copyright © 2022 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575